More support for short course radiation for prostate

ASTRO 2018: John Staffurth, MD, MB, from Cardiff University, gave an update on the progress of the Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer (CHHiP) trial. The five-year findings of this noninferiority trial show evidence that hypofractionation (60 Gray in 20 fractions or 57 Gray in 19 fractions) reduces long-term sexual side effects with no significant effect on bowel or urinary side effects in patients with localized prostate cancer versus a traditional treatment schedule (74 Gray in 37 fractions).


Dr. Vijay Kini specializes in the treatment of cancer using radiation technology and therapies. We are located at 2895 Edinger Avenue, Tustin, CA 92780. We are open from: 8:00 AM to 5:00 PM PST Monday through Friday. Reach out to us at 949-381-5800 for help.

Copyright © 2022 Practice Builders and Dr Vijay Kini, MD. All rights reserved.